TrialCPT: pharmacometrics & systems pharmacology2022

PK/PD modeling links accelerated resolution of COVID-19-related clinical symptoms to SARS-CoV-2 viral load reduction in patients following treatment with Bamlanivimab alone or Bamlanivimab and Etesevimab together.

C Steven Ernest et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.